董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| David W. Golding | 男 | Director | 63 | 26.75万美元 | 10.40 | 2025-10-01 |
| R. Carter Pate | 男 | Director | 71 | 29.50万美元 | 0.17 | 2025-10-01 |
| Elizabeth Q. Betten | -- | Director | 44 | 28.25万美元 | 1.99 | 2025-10-01 |
| Elizabeth D. Bierbower | -- | Director | 66 | 27.85万美元 | 1.52 | 2025-10-01 |
| Barbara W. Bodem | -- | Director | 57 | 27.85万美元 | 0.46 | 2025-10-01 |
| Eric K. Brandt | -- | Director | 62 | 27.85万美元 | 0.35 | 2025-10-01 |
| Natasha Deckmann | -- | Director | 48 | 29.25万美元 | 1.26 | 2025-10-01 |
| Harry M. Jansen Kramer | -- | Non-Executive Chairman of the Board | 70 | 41.60万美元 | 39.13 | 2025-10-01 |
| John C. Rademacher | -- | Chief Executive Officer, President and Director | 58 | 926.63万美元 | 110.25 | 2025-10-01 |
| Timothy P. Sullivan | -- | Director | 67 | 26.75万美元 | 3.77 | 2025-10-01 |
| Norman L. Wright | -- | Director | 60 | 28.75万美元 | 0.80 | 2025-10-01 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Meenal A. Sethna | 女 | Executive Vice President and Chief Financial Officer | 55 | 181.39万美元 | 未持股 | 2025-10-01 |
| John C. Rademacher | -- | Chief Executive Officer, President and Director | 58 | 926.63万美元 | 110.25 | 2025-10-01 |
| Luke Whitworth | -- | Chief Operating Officer | -- | 380.83万美元 | 22.34 | 2025-10-01 |
| Collin G. Smyser | -- | General Counsel and Corporate Secretary | -- | 217.74万美元 | 7.62 | 2025-10-01 |
| Christopher L. Grashoff | -- | Chief Growth Officer | -- | 185.97万美元 | 4.13 | 2025-10-01 |
董事简历
中英对照 | 中文 | 英文- David W. Golding
-
David W. Golding， 2015年5月起担任董事。2011年以来，他曾担任国家管理医疗组织、专业药房供应商、药房福利管理企业和其他医疗保健公司的独立顾问。他目前担任VirMedica， Inc.（医疗技术解决方案公司）的董事；Dunn Meadow Pharmacy，一家专门的疼痛管理药房；和Global Healthcare Integrators（一家国际药物治疗管理提供商）。2013年至2015年，他还担任Salveo Specialty Pharmacy， Inc.（一家独立的专业药房公司）的董事。从1987年到2011年，他在CVS Caremark工作，开始在家庭输液部门担任各种职务，最终担任CVS Health Corporation的药房福利管理和邮件服务药房部门的专业药房执行副总裁。他于1984年获得Illinois大学的药学学士学位，并在Cook County Hospital担任药剂师，在St Anthony’s Memorial Hospital担任临床药剂师。
David W. Golding has been a director since May 2015. Since 2011 Mr. Golding has served as an independent consultant to national managed care organizations, specialty pharmacy providers, pharmacy benefit management businesses and other healthcare companies. Mr. Golding currently serves as a director of VirMedica, Inc., a healthcare technology solutions company; Dunn Meadow Pharmacy, a specialized pain management pharmacy; and Global Healthcare Integrators, an international medication therapy management provider. Mr. Golding also served as a director of Salveo Specialty Pharmacy, Inc., an independent specialty pharmacy company, from 2013 to 2015. From 1987 to 2011 Mr. Golding worked at CVS Caremark, beginning his service in various capacities in the home infusion segment and culminating as Executive Vice President of Specialty Pharmacy within the pharmacy benefit management and mail service pharmacy division of CVS Health Corporation. Mr. Golding received his bachelor's degree in pharmacy from the University of Illinois in 1984 and began his career as a Pharmacist at Cook County Hospital and a Clinical Pharmacist at St Anthony's Memorial Hospital. - David W. Golding， 2015年5月起担任董事。2011年以来，他曾担任国家管理医疗组织、专业药房供应商、药房福利管理企业和其他医疗保健公司的独立顾问。他目前担任VirMedica， Inc.（医疗技术解决方案公司）的董事；Dunn Meadow Pharmacy，一家专门的疼痛管理药房；和Global Healthcare Integrators（一家国际药物治疗管理提供商）。2013年至2015年，他还担任Salveo Specialty Pharmacy， Inc.（一家独立的专业药房公司）的董事。从1987年到2011年，他在CVS Caremark工作，开始在家庭输液部门担任各种职务，最终担任CVS Health Corporation的药房福利管理和邮件服务药房部门的专业药房执行副总裁。他于1984年获得Illinois大学的药学学士学位，并在Cook County Hospital担任药剂师，在St Anthony’s Memorial Hospital担任临床药剂师。
- David W. Golding has been a director since May 2015. Since 2011 Mr. Golding has served as an independent consultant to national managed care organizations, specialty pharmacy providers, pharmacy benefit management businesses and other healthcare companies. Mr. Golding currently serves as a director of VirMedica, Inc., a healthcare technology solutions company; Dunn Meadow Pharmacy, a specialized pain management pharmacy; and Global Healthcare Integrators, an international medication therapy management provider. Mr. Golding also served as a director of Salveo Specialty Pharmacy, Inc., an independent specialty pharmacy company, from 2013 to 2015. From 1987 to 2011 Mr. Golding worked at CVS Caremark, beginning his service in various capacities in the home infusion segment and culminating as Executive Vice President of Specialty Pharmacy within the pharmacy benefit management and mail service pharmacy division of CVS Health Corporation. Mr. Golding received his bachelor's degree in pharmacy from the University of Illinois in 1984 and began his career as a Pharmacist at Cook County Hospital and a Clinical Pharmacist at St Anthony's Memorial Hospital.
- R. Carter Pate
-
R. Carter Pate，自2021年2月起担任董事会成员。他是Carter Pate， LLC（家族私募股权投资公司）的创始人兼首席执行官，自2014年起担任公共和私人董事会成员。他是Providence Service Corp DBA LogistiCare（医疗保险和医疗补助最大的非紧急医疗物流公司）的前首席执行官。他目前担任Optioncare Health的董事会成员，并曾担任其前身bioscript Inc.的董事会主席。他还担任董事会成员，薪酬委员会主席，高级排放解决方案审计委员会成员。他于2019年5月至2021年3月担任Red Lion Hotels Corporation的董事会成员。在担任这些职务之前，他曾在PricewaterhouseCoopers任职近20年，包括担任美国咨询公司的全球/美国管理合伙人，后来担任医疗保健实践负责人。他持有注册会计师和注册法务会计师证书。他持有Greensboro College会计学士学位，以及Texas大学Dallas分校会计与信息管理硕士学位。
R. Carter Pate, has served as a member of Board of Directors since February 2021. Mr. Pate is the founder and Chief Executive Officer of Carter Pate, LLC, a Family Private Equity Investment Company, and has served as a board member to public and private boards of directors since 2014. He is the former Chief Executive Officer of Providence Service Corp DBA LogistiCare, the largest non-emergency medical logistics company for Medicare and Medicaid. Mr. Pate currently serves on the Board of Optioncare Health and was the Chairman of the Board of its predecessor, BioScrip Inc. He also serves as a member of the Board, the Chairman of its Compensation Committee, and a member of the Audit Committee for Advanced Emissions Solutions. Mr. Pate served as a member of the board of directors of Red Lion Hotels Corporation from May 2019 until March 2021. Prior to these roles, Mr. Pate had a career with PricewaterhouseCoopers spanning nearly two decades, including his service as a Global/United States Managing Partner of U.S. Advisory and later the Health Care practice leader.Mr. Pate holds certifications as a Certified Public Accountant and Certified Forensic Public Accountant. Mr. Pate obtained his undergraduate degree in Accounting from Greensboro College and a Masters in Accounting and Information Management from the University of Texas at Dallas. - R. Carter Pate，自2021年2月起担任董事会成员。他是Carter Pate， LLC（家族私募股权投资公司）的创始人兼首席执行官，自2014年起担任公共和私人董事会成员。他是Providence Service Corp DBA LogistiCare（医疗保险和医疗补助最大的非紧急医疗物流公司）的前首席执行官。他目前担任Optioncare Health的董事会成员，并曾担任其前身bioscript Inc.的董事会主席。他还担任董事会成员，薪酬委员会主席，高级排放解决方案审计委员会成员。他于2019年5月至2021年3月担任Red Lion Hotels Corporation的董事会成员。在担任这些职务之前，他曾在PricewaterhouseCoopers任职近20年，包括担任美国咨询公司的全球/美国管理合伙人，后来担任医疗保健实践负责人。他持有注册会计师和注册法务会计师证书。他持有Greensboro College会计学士学位，以及Texas大学Dallas分校会计与信息管理硕士学位。
- R. Carter Pate, has served as a member of Board of Directors since February 2021. Mr. Pate is the founder and Chief Executive Officer of Carter Pate, LLC, a Family Private Equity Investment Company, and has served as a board member to public and private boards of directors since 2014. He is the former Chief Executive Officer of Providence Service Corp DBA LogistiCare, the largest non-emergency medical logistics company for Medicare and Medicaid. Mr. Pate currently serves on the Board of Optioncare Health and was the Chairman of the Board of its predecessor, BioScrip Inc. He also serves as a member of the Board, the Chairman of its Compensation Committee, and a member of the Audit Committee for Advanced Emissions Solutions. Mr. Pate served as a member of the board of directors of Red Lion Hotels Corporation from May 2019 until March 2021. Prior to these roles, Mr. Pate had a career with PricewaterhouseCoopers spanning nearly two decades, including his service as a Global/United States Managing Partner of U.S. Advisory and later the Health Care practice leader.Mr. Pate holds certifications as a Certified Public Accountant and Certified Forensic Public Accountant. Mr. Pate obtained his undergraduate degree in Accounting from Greensboro College and a Masters in Accounting and Information Management from the University of Texas at Dallas.
- Elizabeth Q. Betten
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Elizabeth D. Bierbower
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Barbara W. Bodem
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Eric K. Brandt
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Natasha Deckmann
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Harry M. Jansen Kramer
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- John C. Rademacher
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Timothy P. Sullivan
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Norman L. Wright
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
高管简历
中英对照 | 中文 | 英文- Meenal A. Sethna
Meenal A. Sethna，负责公司风险、投资者关系和金融规划和分析。2016年3月31日正式成为公司执行副总裁和首席财务官。2015年加入公司，在此之前Sethna从2011年到2015年担任Illinois Tool Works Inc.（一家全球工业产品和设备制造商）副总裁和企业总监。在此之前，Sethna从2004年到2010年在Motorola, Inc.任职。
Meenal A. Sethna,has served as Executive Vice President and Chief Financial Officer of Littelfuse, Inc., a diversified, industrial technology manufacturing company, since 2016 and is responsible for finance and accounting, tax and treasury, investor relations, digital and information technology and internal audit as well as supply chain operations. Prior to joining Littelfuse in May, 2015, Ms. Sethna spent four years at Illinois Tool Works as Vice President and Corporate Controller. Previous to that, she worked at Motorola Inc., most recently as Vice President, Finance. She began her career at Baxter International, holding a variety of finance roles during her tenure. Ms. Sethna is a graduate of the Kellogg School of Management at Northwestern University and the University of Illinois-Urbana, and is a Certified Public Accountant in Illinois.- Meenal A. Sethna，负责公司风险、投资者关系和金融规划和分析。2016年3月31日正式成为公司执行副总裁和首席财务官。2015年加入公司，在此之前Sethna从2011年到2015年担任Illinois Tool Works Inc.（一家全球工业产品和设备制造商）副总裁和企业总监。在此之前，Sethna从2004年到2010年在Motorola, Inc.任职。
- Meenal A. Sethna,has served as Executive Vice President and Chief Financial Officer of Littelfuse, Inc., a diversified, industrial technology manufacturing company, since 2016 and is responsible for finance and accounting, tax and treasury, investor relations, digital and information technology and internal audit as well as supply chain operations. Prior to joining Littelfuse in May, 2015, Ms. Sethna spent four years at Illinois Tool Works as Vice President and Corporate Controller. Previous to that, she worked at Motorola Inc., most recently as Vice President, Finance. She began her career at Baxter International, holding a variety of finance roles during her tenure. Ms. Sethna is a graduate of the Kellogg School of Management at Northwestern University and the University of Illinois-Urbana, and is a Certified Public Accountant in Illinois.
- John C. Rademacher
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Luke Whitworth
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Collin G. Smyser
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Christopher L. Grashoff
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介